捷普美股招股说明书(2025-01-27版)

PROSPECTUS SUPPLEMENT(To Prospectus Dated July 3, 2023) 1,158,539 Shares ofCommon Stock This prospectus supplement relates to the offer and resale, from time to time, of up to 1,158,539 shares of ourcommon stock, par value $0.001 per share (the “common stock”), that may be issuable upon exercise of the warrant(the “warrant”) held by the selling securityholder (the “selling securityholder”) identified in this prospectussupplement. The exercise price, and therefore the number of shares of our common stock issuable to the selling securityholderupon exercise of the warrant, is subject to adjustment in certain circumstances. Accordingly, the number of shares ofour common stock issuable with respect to the warrant may increase or decrease. We are not offering or selling any shares of our common stock under this prospectus supplement and will notreceive any proceeds from the sale of shares of our common stock covered by this prospectus supplement. We willpay all expenses of the registration of the common stock and certain other fees and expenses incident to theregistration of shares of our common stock. The selling securityholder will act independently in making decisions with respect to the timing, manner and size ofany sale or non-sale related transfer. Our registration of the securities covered by this prospectus supplement doesnot mean that the selling securityholder will offer or sell any of the shares of our common stock offered hereby. Theselling securityholder may sell the securities in one or more transactions at the market price for our common stockprevailing at the time of sale, a price related to the prevailing market price, a negotiated price or such other price asthe selling securityholder determines from time to time. See “Plan of Distribution.” Our common stock is listed on the New York Stock Exchange (the “NYSE”) under the symbol “JBL.” OnJanuary 23, 2025, the closing price of our common stock on NYSE was $171.24 per share, respectively. Investing in our common stock involves risks. See “Risk Factors” beginning on page S-4 of thisprospectus supplement and in the documents incorporated by reference in this prospectussupplement and the accompanying prospectus for a description of risks you should consider whenevaluating such investment. Neither the Securities and Exchange Commission (the “SEC”) nor any state, provincial or territorialsecurities commission, nor any other regulatory body has approved or disapproved of these securities or determined if this prospectus supplement and the prospectus to which it relates are truthful and complete.Any representation to the contrary is a criminal offense. The date of this prospectus supplement is January 27, 2025. Table of Contents TABLE OF CONTENTS Prospectus Supplement PageAbout This Prospectus SupplementS-iiCautionary Statement Regarding Forward-Looking StatementsS-iiiSummaryS-1Risk FactorsS-4Use of ProceedsS-5Selling SecurityholderS-6U.S. Federal Income Tax ConsiderationsS-8Plan of DistributionS-11Legal MattersS-14Where You Can Find More InformationS-14Incorporation of Certain Documents by ReferenceS-14 Prospectus About This ProspectusDisclosure Regarding Forward-Looking StatementsJabil Inc.Risk FactorsUse of ProceedsDescription of Debt SecuritiesDescription of Capital StockDescription of Warrants Description of Depositary SharesPlan of DistributionLegal MattersExpertsWhere You Can Find More InformationIncorporation by Reference Table of Contents ABOUT THIS PROSPECTUS SUPPLEMENT This document is in two parts. The first part is this prospectus supplement, which describes the specific terms of thisoffering and the securities offered hereby. The second part is the accompanying prospectus, which gives moregeneral information about us and the securities that we may offer from time to time. This prospectus supplementalso adds, updates and changes information contained in the accompanying prospectus. If there is any inconsistencybetween the information in this prospectus supplement and the accompanying prospectus, you should rely on theinformation in this prospectus supplement. This prospectus supplement, the accompanying prospectus and thedocuments incorporated into each by reference include important information about us, the common stock beingoffered and other information you should know before investing. You should read this prospectus supplement andthe accompanying prospectus together with the additional information described under the heading, “Where YouCan Find More Information” before investing in our common stock. Any statement in this prospectus supplement or in a document incorporated or deemed to be incorporated byreference in this prospectus supplement will be deemed to be modified or superseded for purposes of this prospectussupplement to the extent that a statement contained herein or in any other subsequently filed document that is alsoincorporated or deemed incorporated by reference in this prospectus supplement modifies or